HomeAbout SPIFor PatientsFor PhysiciansSPI DoctorsDirections206.215.2480

Clinical Training CoursesTechnical AssistanceBrachytherapy ConferencePCa Commentary



PCa Commentary
 

Androgen Deprivation and Memory Loss. (April 2006)

Research conducted by Dr. Tomasz Beer and colleagues have documented a consequence of androgen deprivation that may often be too subtle to be detected in clinical practice in individual patients - that testosterone deficiency is associated with memory impairment. Their study, “Testosterone Loss and Estradiol Administration Modify Memory in Men”, J Urol. Jan 2006, used a battery of tests to evaluate memory in 18 men on androgen deprivation therapy (ADT), 17 men on ADT combined with transdermal estradiol, and 17 healthy control subjects. All men on ADT had serum testosterone levels of < 50 ng/dl.

There is a sound biologic basis for this finding. The cortical centers that process memory - the prefrontal cortex and the amygdala and hyppocampus - are rich in sex steroid receptors, and alterations in steroid levels might be expected to affect neurophysiological function. Studies have shown that “gonadectomy results in a 40% or greater reduction of synaptic spine density in the CA1 region of the hyppocampus in male monkeys and rats, and androgen replacement restores synapse number to pre-gonadectory levels in male rats”. Adverse consequences of ADT have previously been reported in prostate cancer patients which “decrease memory, attention or executive function”.

Beer’s research assessed immediate and delayed verbal memory by testing the subjects’ recall immediately after two paragraphs were read to them, and then testing again 30 minutes later. Cognitive tests and Profile of Mood State assessment established that ADT was associated with greater confusion, fatigue, depression, and decreased vigor compared to the healthy controls. Another assessment indicated that the men on ADT exhibited a “slower processing speed”, although tests of working memory found no significant difference among the three groups. The concomitant exposure to estrogen did not ameliorate the adverse effects of ADT. Since the study was small, the authors acknowledge that confirmation would strengthen and clarify their findings.

Their conclusion: “Thus, long-term androgen deprivation therapy has the potential to significantly affect cognition with particular effects on memory”. Their recommendation: When ADT is an option the “potential for cognitive toxicity of treatment should be considered in the risk-benefit calculation”.

« Back to Article List


(c) 2006 Seattle Prostate Institute -  All rights reserved.